 | abx269927 | Receptor-Binding Cancer Antigen Expressed On SiSo Cells (EBAG9) Peptide | 100 µg | Sign In for Pricing | |
 | MBS9619838-01 | SNCG (breast cancer-specific protein 1) Blocking Peptide | 1 mg | Sign In for Pricing | |
| MBS9619838-02 | SNCG (breast cancer-specific protein 1) Blocking Peptide | 5x 1 mg | Sign In for Pricing | |
| CRB1000020-01 | Proapoptotic Peptide KLA - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
| CRB1000020-02 | Proapoptotic Peptide KLA - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
| M2749-31H1 | MCM3, Control Peptide, Human (Cervical Cancer Proto-oncogene 5, DNA Polymerase alpha Holoenzyme Associated Protein P1, DNA Replication Licensing Factor MCM3, HCC5, hRlf beta Subunit, Human Cervical Cancer Proto-oncogene 5, MGC1157, Minichromosome Maintenance Deficient 3, Minichromosome Maintenance Protein 3, P1-h, P1.h, P1-MCM3, P1-Protein, P102 Protein, Replication Licensing Factor beta Subunit, RLF beta Subunit, RLF Subunit beta, RLFB) discontinued | 50 µg | Sign In for Pricing | |
| 147705 | BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308) | 100 µg | Sign In for Pricing | |
 | 147719 | BRDT, Control Peptide (Bromodomain Testis-specific Protein, RING3-like Protein, Cancer/Testis Antigen 9, CT9) | 100 µg | Sign In for Pricing | |
 | 148131 | LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073) | 100 µg | Sign In for Pricing | |
| 148615 | TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5) | 100 µg | Sign In for Pricing | |
| 148688 | XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) | 100 µg | Sign In for Pricing | |
| 149304 | ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261) | 50 µg | Sign In for Pricing | |
| 148781 | PTPRH, Control Peptide (Receptor-type Tyrosine-protein Phosphatase H, R-PTP-H, Stomach Cancer-associated Protein Tyrosine Phosphatase 1, SAP-1, Transmembrane-type Protein-tyrosine Phosphatase Type H, SAP1, FLJ39938, MGC133058, MGC133059) | 100 µg | Sign In for Pricing | |
| 149479 | CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1) | 50 µg | Sign In for Pricing | |
| AP-305-B | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Biotinylated | 1 mg | Sign In for Pricing | |
| AP-306-U | Human Colorectal Cancer WiDr Cell Line (HEW-K16), Peptide Aptamer, unlabeled | 5 mg | Sign In for Pricing | |
| AP-306-F | Human Colorectal Cancer WiDr Cell Line (HEW-K16), Peptide Aptamer, FITC labelled | 1 mg | Sign In for Pricing | |
| AP-305-U | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, unlabeled | 5 mg | Sign In for Pricing | |
| L-015 | Cancer-Targeting Peptide Library | 289 Peptides | Sign In for Pricing | |
| HY-P10790 | Breast cancer targeting peptide 18–4 | 1 Each | Sign In for Pricing | |
| TP3074-01 | Breast cancer targeting peptide 18–4 | 10 mg | Sign In for Pricing | |
| TP3074-02 | Breast cancer targeting peptide 18–4 | 50 mg | Sign In for Pricing | |
| CRB1000940-01 | ARF peptide - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
| CRB1000940-02 | ARF peptide - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
| CRB1001174-01 | FREG peptide - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
| CRB1001174-02 | FREG peptide - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
| CRB1001194-01 | RAGE antagonist peptide - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
| CRB1001194-02 | RAGE antagonist peptide - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
| N5379-06-P | N33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinued | 100 µg | Sign In for Pricing | |
| 220315 | TFF1, Recombinant, Human (TFF-1, pS2, BCEI, HPS, HP1, A, pNR-2, D21S21, pS2 Protein, Trefoil Factor 1, Breast Cancer Estrogen-Inducible Protein, Trefoil Factor Peptide, pS2 Protein, HP1.A, Breast Cancer Estrogen-Inducible Protein (BCEI), PNR2) discontinued | 20 µg | Sign In for Pricing | |
| 220316 | TFF2, Recombinant, Human (SP, SML1, TFF-2, Trefoil Factor 2, Trefoil Factor peptide, pS2 protein, HP1.A, Breast Cancer Estrogen-Inducible protein, BCEI, PNR2) discontinued | 20 µg | Sign In for Pricing | |
| 147875 | EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1) | 100 µg | Sign In for Pricing | |
| 148130 | LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073) | 100 µg | Sign In for Pricing | |
| 148183 | MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453) | 100 µg | Sign In for Pricing | |
| 148198 | MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063) | 100 µg | Sign In for Pricing | |
| 148480 | SEPT1, Control Peptide (Septin-1, LARP, Peanut-like Protein 3, Serologically Defined Breast Cancer Antigen NY-BR-24, DIFF6, PNUTL3, MGC20394) | 100 µg | Sign In for Pricing | |
| 148687 | XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued | 100 µg | Sign In for Pricing | |
| 148719 | CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag) | 100 µg | Sign In for Pricing | |
| 149231 | MACC1, Control Peptide (Metastasis-associated in Colon Cancer Protein 1, SH3 Domain-containing Protein 7a5) | 50 µg | Sign In for Pricing | |
| 149384 | BCAS1, Control Peptide (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) | 50 µg | Sign In for Pricing | |
| 149417 | WDR40A, Control Peptide (DCAF12, KIAA1892, TCC52, WDR40A, DDB1-and CUL4-associated Factor 12, Centrosome-related Protein TCC52, Testis Cancer Centrosome-related Protein, WD Repeat-containing Protein 40A) | 50 µg | Sign In for Pricing | |
| orb2942802-01 | Breast cancer targeting peptide 18–4 | 50 mg | Sign In for Pricing | |
| orb2942802-02 | Breast cancer targeting peptide 18–4 | 10 mg | Sign In for Pricing | |
| orb1504092 | Cancer/testis antigen 1.11 Antibody Blocking Peptide | 500 µg | Sign In for Pricing | |
| AP-306-B | Human Colorectal Cancer WiDr Cell Line (HEW-K16), Peptide Aptamer, Biotinylated | 1 mg | Sign In for Pricing | |
| AB-23028-P | Zebra fish breast and ovarian cancer susceptibility protein 2 (BRCA2) Control/blocking peptide | 100 µg | Sign In for Pricing | |
| AP-319-U | Peritoneal tumors of gastric cancer, Peptide Aptamer, unlabeled | 5 mg | Sign In for Pricing | |
| AP-319-F | Peritoneal tumors of gastric cancer, Peptide Aptamer, FITC labelled | 1 mg | Sign In for Pricing | |
| AP-305-F | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, FITC labelled | 1 mg | Sign In for Pricing | |
| abx615811 | Cancer/Testis Antigen 1 (CTAG1B) Peptide | 100 µg | Sign In for Pricing | |